Cargando…
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
Background: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, immune-mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD therapies, designed for continuous immune suppression, often render patients more susceptible to infections. The effect of the immun...
Ejemplares similares
-
Eva Between Anxiety and Hope: Integrating Anthroposophic Music Therapy in Supportive Oncology Care
por: Ben-Arye, Eran, et al.
Publicado: (2015) -
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study
por: Albshesh, Ahmad, et al.
Publicado: (2023) -
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
por: Edelman-Klapper, Hadar, et al.
Publicado: (2023) -
Integration of Herbal Medicine in Primary Care in Israel: A Jewish-Arab Cross-Cultural Perspective
por: Ben-Arye, Eran, et al.
Publicado: (2011) -
Feasibility of an Online Integrative Oncology Treatment Program During COVID-19
por: Ben-Arye, Eran, et al.
Publicado: (2021)